Growth hormone deficiency, its influence on bone mineral density and incidence of osteoporotic fractures;Deficit rastového hormónu a jeho vplyv na kostnú minerálnu denzitu a riziko osteoporotických fraktúr

Casopis Lekaru Ceskych

Volumn 149, Issue 5, 2010, Pages 211-216

  Kužma, Martin ^a   Payer, Juraj ^a  

^a Faculty of Natural Sciences   (Slovakia)

Author keywords

Bone density; Fractures; Growth hormone; IGF I; Peak bone mass

Indexed keywords

EID: 77953119463     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Mohsen S, Eledrisi, MD. FACP, FACE, Consultant, Department of Internal Medicine, Division of Endocrinology and Metabolism. King Abdulaziz National Guard Medical Center, Saudi Arabia 2009
2. Kužma M, Payer J. Deficit rastového hormónu v dospelosti. Slovenský lekár, 2009; 19(33): 131-138.
3. Rizzoli R, Bonjour JP. Determinants of peak bone mass and mechanisms of bone loss. Osteoporos Int 1999; 9 (Suppl. 2): S17-S23.
4. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev 1998; 19(1): 55-79.
5. Bouillon R. Growth hormone and bone. Horm Res 1991; 36 (Suppl. 1): 49-55.
6. de Boer H, Blok GJ, van der Veen, EA. Clinical aspects of growth hormone deficiency in adults. Department of Endocrinology, Free University Hospital, Amsterdam, The Netherlands. Endocr Rev 1995; 16(1): 63-86.
7. Johansson AG, Burman P, Westermark K, Ljunghall S. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 1992; 232(5): 447-452.
8. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994; 78(3): 669-674.
9. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992; 74(1): 118-123.
10. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 1997; 82(1): 82-88.
11. Rosén T, Hansson T, Granhed H, Szucs J, Bengtsson BA. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993; 129(3): 201-206. (Pubitemid 23295680)
12. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 1992; 36(1): 45-52.
13. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 1992; 37(1): 79-87.
14. Vandeweghe M, Taelman P, Kaufman JM. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf) 1993; 39(4): 409-415.
15. Johansson AG, Engström BE, Ljunghall S, Karlsson FA, Burman P. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 1999; 84(6): 2002-2007.
16. Johansson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson B-A. Two zears of growth hormone treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin endocrinol Metab 1996; 81: 2865-2873.
17. Baum HBA, Biller BMK, Finkelstein JS, Baker CK, Oppenhein DS, Schoenfeld DA, Hoskins MT, Wittink H, Klibanski A. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 883-890.
18. Välimäkl MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turunen H, Soppl E. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults. Eur J Endocrinol 1999; 140(6): 545-554.
19. Janssen YJ, Hamdy NA, Frölich M, Roelfsema F. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1998; 83(6): 2143-2418.
20. Longobardi S, Di Rella F, Pivonello R, Di Somma C, Klain M, Maurelll L, Scarpa R, Colao A, Merola B, Lombardi G. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. J Endocrinol Invest 1999; 22(5): 333-339.
21. Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol (Oxf) 1998; 48(5): 561-568.
22. Holmes SJ, Whitehouse RW, Economou G, O'Halloran DJ, Adams JE, Shalet SM. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin Endocrinol (Oxf) 1995; 42(1): 3-7.
23. Rahim A, Holmes SJ, Adams JE, Shalet SM. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Clin Endocrinol (Oxf) 1998; 48(4): 463-469.
24. Seeman E, Hopper JL, Bach LA, Cooper ME, Parkinson E, McKay J, Jerums G. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 1989; 320(9): 554-558.
25. Wüster C, Slenczka E, Ziegler R. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: Is there a need for additional growth hormone substitution? (In German). Klin Wochenschr 1991;69:769-773.
26. Rosén T, Wilhelmsen L, Landin-Whilhelmsen K, Lappas G, Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997; 137:240-245.
27. Wüster C, Abs R, Bengtsson BÅ, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P on behalf of the KIMS study group the KIMS international board. The influence of growth hormone deficiency, growth hormone replacement therapy and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001; 2:398-405.
28. Wang MC, Bachrach LK, Van Loan M, Hudes M, Flegal KM, Crawford PB. The relative contribution of lean tissue mass and fat mass to bone density in young women. Bone 2005; 37: 474-481.
29. De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, Elsman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ III, Meunier PJ, Pols HAP, Reeve J, Silman A, Tenenhouse A. Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int 2005; 16: 1330-1338.
30. Kiel DP, Zhang Y, Hannan MT, Anderson JJ, Baron JA, Felson DT. The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos Int 1996;6:240-248.
31. Becker W, Pearson M. Riksmaten 1997-1998, National Food Administration 1998.
32. Slemenda CW, Miller JZ, Hul SL, Reister TK, Johnston CC Jr. Role of physical activity in the development of skeletal mass in children. J Bone Miner Res 1991; 6: 1227-1233.
33. Davee AM, Rosen CJ, Adler RA. Exercise patterns and trabecular bone density in college women. J Bone Miner Res 1990; 5: 245-250.
34. Margulies JY, Simkin A, Lelchter I, Blvas A, Steinberg R, Giladi M, Stein M, Kashtan H, Milgrom C. Effect of intense physical activity on the bone-mineral content in the lower limbs of young adults. J Bone Joint Surg Am 1986; 68: 1090-1093.
35. Holmer H, Svensson J, Rylander L, Johannsson G, Rosén T, Bengtsson BA,Thorén M, Höybye C, Degerblad M, Bramnert M, Hägg E, Engström BE, Ekman B, Thorngren KG, Hagmar L, Erfurth EM. Fracture incidence in GH-deficient patients on complete hormone replacement including GH. J Bone Miner Res 2007; 22(12): 1842-1850.
36. Holmer H, Svensson J, Rylander L, Johannsson G, Rosén T, Bengtsson BA, Thorén M, Höybye C, Degerblad M, Bramnert M, Hägg E, Engström BE, Ekman B, Thorngren KG, Hagmar L, Erfurth EM. Fracture incidence in GH-deficient patients on complete hormone replacement including GH. J Bone Miner Res 2007; 22(12): 1842-1850.
37. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 1990; 5(6): 609-618.
38. Johansson AG, Llndh E, Blum WF, Kollerup G, SŅrensen OH, Ljunghall S. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1996; 81(1): 44-48.
39. Nielsen HK, JŅrgensen JO, Brixen K, Christiansen JS. Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH. Calcif Tissue Int 1991; 48(2): 82-87.
40. Jensen LT, Jorgenssen JOL, Risteli J, Christiansen JS, Lorenzen I. Type I and III procolagen propeptides in growth hormone-deficient patients: Effects of increasing doses of GH. Acta Endocrinol (Copenh) 1991; 124: 278-282.
41. Eden EB, Karlsson FA, Wide L. Marked gender differences in ambulatory morning growth hormone values in young adults. Clin Chem 1998; 44: 1289-1295.
42. Jansson JO, Edén S, Isaksson O. Sexual dimorphism in the control of growth hormone secretion. Endocr Rev 1985; 6(2): 128-150.
43. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, JŅrgensen K, Müller J, Hall K, Skakkebaek NE. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994; 78(3): 744-752.
44. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997; 82(2): 550-555. (Pubitemid 27068627)
45. Cook DM, Ludlam WH, Cook MB. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 1999; 84(11): 3956-3960.